CBX3 and osteosarcoma: In addition, other studies have shown that the overexpression of CBX3 in osteosarcoma (13), tongue squamous carcinoma (14) and breast cancer (15) can adversely affect the prognosis by promoting the occurrence as well as the development of tumors.